Risk factors for methicillin-resistant Staphylococcus aureus colonization and infection in patients with human immunodeficiency virus infection: A systematic review and meta-analysis. Issue 1 (January 2022)
- Record Type:
- Journal Article
- Title:
- Risk factors for methicillin-resistant Staphylococcus aureus colonization and infection in patients with human immunodeficiency virus infection: A systematic review and meta-analysis. Issue 1 (January 2022)
- Main Title:
- Risk factors for methicillin-resistant Staphylococcus aureus colonization and infection in patients with human immunodeficiency virus infection: A systematic review and meta-analysis
- Authors:
- Hu, Xuefei
Hu, Keao
Liu, Yanling
Zeng, Lingbing
Hu, Niya
Chen, Xiaowen
Zhang, Wei - Abstract:
- Objective: To investigate the potential factors affecting methicillin-resistant Staphylococcus aureus (MRSA) colonization and infection in patients with human immunodeficiency virus (HIV) infection. Methods: A systematic search of publications listed in electronic from inception up to August 2020 was conducted. A random-effects model was used to calculate odds ratio (OR) with 95% confidence interval (CI). Results: A total of 31 studies reporting 1410 MRSA events in 17 427 patients with HIV infection were included. Previous hospitalization (OR 1.80; 95% CI 1.37, 2.36), previous antibiotic therapy (OR 2.69; 95% CI 2.09, 3.45), CD4+ count (OR 1.79; 95% CI 1.41, 2.28), Centers for Disease Control and Prevention classification of stage C (OR 2.66; 95% CI 1.80, 3.93), skin lesions (OR 2.02; 95% CI 1.15, 3.55), intravenous device use (OR 2.61; 95% CI 1.59, 4.29) and an MRSA colonization history (OR 6.30; 95% CI 2.50, 15.90) were significantly associated with an increased risk of MRSA colonization and infection. Antiretroviral therapy (OR 0.71; 95% CI 0.50, 0.99) and current antibiotic use (OR 0.13; 95% CI 0.05, 0.32) were significantly associated with a reduced risk of MRSA colonization and infection. Conclusion: MRSA colonization and infection in HIV-infected patients is associated with a number of risk factors.
- Is Part Of:
- Journal of international medical research. Volume 50:Issue 1(2022)
- Journal:
- Journal of international medical research
- Issue:
- Volume 50:Issue 1(2022)
- Issue Display:
- Volume 50, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 50
- Issue:
- 1
- Issue Sort Value:
- 2022-0050-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-01
- Subjects:
- Methicillin-resistant Staphylococcus aureus -- human immunodeficiency virus -- skin and soft-tissue infections -- comprehensive risk stratification
Medicine -- Periodicals
Pharmacology -- Periodicals
610.5 - Journal URLs:
- http://imr.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/03000605211063019 ↗
- Languages:
- English
- ISSNs:
- 0300-0605
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19272.xml